Search Results

There are 4963 results for: content related to: A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C

  1. You have free access to this content
    Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: Results from the hepatitis C antiviral long-term treatment against cirrhosis trial

    Hepatology

    Volume 55, Issue 4, April 2012, Pages: 1019–1029, Gregory T. Everson, Mitchell L. Shiffman, John C. Hoefs, Timothy R. Morgan, Richard K. Sterling, David A. Wagner, Shannon Lauriski, Teresa M. Curto, Anne Stoddard, Elizabeth C. Wright and the HALT-C Trial Group

    Version of Record online : 1 MAR 2012, DOI: 10.1002/hep.24752

  2. You have free access to this content
    Risk prediction of hepatocellular carcinoma in patients with cirrhosis: The ADRESS-HCC risk model

    Cancer

    Volume 120, Issue 22, November 15, 2014, Pages: 3485–3493, Jennifer A. Flemming, Ju Dong Yang, Eric Vittinghoff, W. Ray Kim and Norah A. Terrault

    Version of Record online : 16 JUL 2014, DOI: 10.1002/cncr.28832

  3. You have free access to this content
    Outcome of sustained virological responders with histologically advanced chronic hepatitis C

    Hepatology

    Volume 52, Issue 3, September 2010, Pages: 833–844, Timothy R. Morgan, Marc G. Ghany, Hae-Young Kim, Kristin K. Snow, Mitchell L. Shiffman, Jennifer L. De Santo, William M. Lee, Adrian M. Di Bisceglie, Herbert L. Bonkovsky, Jules L. Dienstag, Chihiro Morishima, Karen L. Lindsay, Anna S. F. Lok and and the HALT-C Trial Group

    Version of Record online : 14 MAY 2010, DOI: 10.1002/hep.23744

  4. You have free access to this content
    Systematic review: identifying patients with chronic hepatitis C in need of early treatment and intensive monitoring – predictors and predictive models of disease progression

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 8, October 2014, Pages: 863–879, M. A. Konerman, S. Yapali and A. S. Lok

    Version of Record online : 28 AUG 2014, DOI: 10.1111/apt.12921

  5. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  6. You have free access to this content
    Improvement of predictive models of risk of disease progression in chronic hepatitis C by incorporating longitudinal data

    Hepatology

    Volume 61, Issue 6, June 2015, Pages: 1832–1841, Monica A. Konerman, Yiwei Zhang, Ji Zhu, Peter D.R. Higgins, Anna S.F. Lok and Akbar K. Waljee

    Version of Record online : 20 MAR 2015, DOI: 10.1002/hep.27750

  7. Applicability of MELD as a short-term prognostic indicator in patients with chronic liver disease: An Indian experience

    Journal of Gastroenterology and Hepatology

    Volume 22, Issue 8, August 2007, Pages: 1232–1235, Peeyush Mishra, Nutan Desai, Jacob Alexander, Dharmendra P Singh and Prabha Sawant

    Version of Record online : 21 MAR 2007, DOI: 10.1111/j.1440-1746.2007.04903.x

  8. Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decompensated cirrhosis

    Liver International

    Volume 32, Issue 4, April 2012, Pages: 656–664, Jong Jin Hyun, Yeon Seok Seo, Eileen Yoon, Tae Hyung Kim, Dong Jin Kim, Hyun Seok Kang, Eun Suk Jung, Jeong Han Kim, Hyonggin An, Ji Hoon Kim, Hyung Joon Yim, Jong Eun Yeon, Hong Sik Lee, Kwan Soo Byun, Soon Ho Um, Chang Duck Kim and Ho Sang Ryu

    Version of Record online : 17 NOV 2011, DOI: 10.1111/j.1478-3231.2011.02676.x

  9. You have free access to this content
    Systematic review: the model for end-stage liver disease – should it replace Child-Pugh's classification for assessing prognosis in cirrhosis?

    Alimentary Pharmacology & Therapeutics

    Volume 22, Issue 11-12, December 2005, Pages: 1079–1089, E. CHOLONGITAS, G. V. PAPATHEODORIDIS, M. VANGELI, N. TERRENI, D. PATCH and A. K. BURROUGHS

    Version of Record online : 2 NOV 2005, DOI: 10.1111/j.1365-2036.2005.02691.x

  10. You have free access to this content
    Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon

    Hepatology

    Volume 53, Issue 4, April 2011, Pages: 1100–1108, Adrian M. Di Bisceglie, Anne M. Stoddard, Jules L. Dienstag, Mitchell L. Shiffman, Leonard B. Seeff, Herbert L. Bonkovsky, Chihiro Morishima, Elizabeth C. Wright, Kristin K. Snow, William M. Lee, Robert J. Fontana, Timothy R. Morgan, Marc G. Ghany and for the HALT-C Trial Group

    Version of Record online : 7 APR 2011, DOI: 10.1002/hep.24169

  11. The value of model for end-stage liver disease and Child–Turcotte–Pugh scores over time in evaluating the prognosis of patients with decompensated cirrhosis: experience in the Chinese mainland

    Hepatology Research

    Volume 39, Issue 8, August 2009, Pages: 779–785, Cai-qun Bie, Dong-hua Yang, Shao-hui Tang and Wei Huang

    Version of Record online : 7 APR 2009, DOI: 10.1111/j.1872-034X.2009.00514.x

  12. You have free access to this content
    Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial

    Hepatology

    Volume 49, Issue 6, June 2009, Pages: 1847–1858, Tania Mara Welzel, Timothy R. Morgan, Herbert L. Bonkovsky, Deepa Naishadham, Ruth M. Pfeiffer, Elizabeth C. Wright, Amy A. Hutchinson, Andrew T. Crenshaw, Arman Bashirova, Mary Carrington, Myhanh Dotrang, Richard K. Sterling, Karen L. Lindsay, Robert J. Fontana, William M. Lee, Adrian M. Di Bisceglie, Marc G. Ghany, David R. Gretch, Stephen J. Chanock, Raymond T. Chung, Thomas R. O'Brien and HALT-C Trial Group

    Version of Record online : 2 FEB 2009, DOI: 10.1002/hep.22877

  13. ADAMTS13 activity may predict the cumulative survival of patients with liver cirrhosis in comparison with the Child-Turcotte-Pugh score and the Model for End-Stage Liver Disease score

    Hepatology Research

    Volume 42, Issue 5, May 2012, Pages: 459–472, Hiroaki Takaya, Masahito Uemura, Yoshihiro Fujimura, Masanori Matsumoto, Tomomi Matsuyama, Seiji Kato, Chie Morioka, Hiromichi Ishizashi, Yuji Hori, Masao Fujimoto, Tatsuhiro Tsujimoto, Hideto Kawaratani, Masahisa Toyohara, Norio Kurumatani and Hiroshi Fukui

    Version of Record online : 31 JAN 2012, DOI: 10.1111/j.1872-034X.2011.00950.x

  14. You have free access to this content
    A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation

    Liver Transplantation

    Volume 12, Issue 7, July 2006, Pages: 1049–1061, Evangelos Cholongitas, Laura Marelli, Vibhakorn Shusang, Marco Senzolo, Keith Rolles, David Patch and Andrew K. Burroughs

    Version of Record online : 23 JUN 2006, DOI: 10.1002/lt.20824

  15. You have free access to this content
    Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C

    Hepatology

    Volume 47, Issue 3, March 2008, Pages: 789–798, Robert J. Fontana, Zachary D. Goodman, Jules L. Dienstag, Herbert L. Bonkovsky, Deepa Naishadham, Richard K. Sterling, Grace L. Su, Mita Ghosh, Elizabeth C. Wright and HALT-C Trial Group

    Version of Record online : 3 JAN 2008, DOI: 10.1002/hep.22099

  16. You have free access to this content
    Fibrosis progression in chronic hepatitis C: Morphometric image analysis in the HALT-C trial

    Hepatology

    Volume 50, Issue 6, December 2009, Pages: 1738–1749, Zachary D. Goodman, Anne M. Stoddard, Herbert L. Bonkovsky, Robert J. Fontana, Marc G. Ghany, Timothy R. Morgan, Elizabeth C. Wright, Elizabeth M. Brunt, David E. Kleiner, Mitchell L. Shiffman, Gregory T. Everson, Karen L. Lindsay, Jules L. Dienstag, Chihiro Morishima and HALT-C Trial Group

    Version of Record online : 5 AUG 2009, DOI: 10.1002/hep.23211

  17. You have free access to this content
    Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients

    Liver Transplantation

    Volume 8, Issue 3, March 2002, Pages: 278–284, Robert S. Brown Jr, K. Shiva Kumar, Mark W. Russo, Milan Kinkhabwala, Dianne L. Rudow, Patricia Harren, Steven Lobritto and Jean C. Emond

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jlts.2002.31340

  18. You have free access to this content
    Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: A longitudinal analysis

    Hepatology

    Volume 58, Issue 5, November 2013, Pages: 1548–1557, Mazen Noureddin, Elizabeth C. Wright, Harvey J. Alter, Shauna Clark, Emmanuel Thomas, Richard Chen, Xiongce Zhao, Cathy Conry-Cantilena, David E. Kleiner, T. Jake Liang and Marc G. Ghany

    Version of Record online : 30 SEP 2013, DOI: 10.1002/hep.26506

  19. You have free access to this content
    Predicting clinical outcomes using baseline and follow-up laboratory data from the hepatitis C long-term treatment against cirrhosis trial

    Hepatology

    Volume 54, Issue 5, November 2011, Pages: 1527–1537, Marc G. Ghany, Hae-Young Kim, Anne Stoddard, Elizabeth C. Wright, Leonard B. Seeff, Anna S.F. Lok and the HALT-C Trial Group

    Version of Record online : 28 OCT 2011, DOI: 10.1002/hep.24550

  20. You have free access to this content
    Improving liver allocation: MELD and PELD

    American Journal of Transplantation

    Volume 4, Issue s9, April 2004, Pages: 114–131, Richard B. Freeman Jr, Russell H. Wiesner, John P. Roberts, Suzanne McDiarmid, Dawn M. Dykstra and Robert M. Merion

    Version of Record online : 14 MAY 2004, DOI: 10.1111/j.1600-6135.2004.00403.x